Tweet
The Temosure 100 capsule acts as an alkylating substance that is utilized for the treatment procedure of glioblastoma multiforme as well as refractory anaplastic astrocytoma. These two forms of cancers are malignant brain tumors having a poor prognosis along with the Limited therapeutic options.
The chief component present in the Temosure 100 capsule is Temozolomide 100 mg. This component got its approval from FDA in the year 1999. This is in the form of the oral capsule as well as subsequently as the intravenous injection.
The chief component present in the Temosure 100 capsule is Temozolomide 100 mg. This component got its approval from FDA in the year 1999. This is in the form of the oral capsule as well as subsequently as the intravenous injection.